what is microdosing for glp 1 GLP-1s: Safety, Dosage, Side Effects, and Results What is GLP-1 Microdosing? |

February 5, 2024

21+ only

BelaunzaranZamudio at the National Institute of Allergy and Infectious Diseases

Expected outcomes based on trial data: Average weight loss of 24.2% at 48 weeks (phase 2) Average weight loss of 28.7% at 68 weeks (phase 3, TRIUMPH-4) 100% of participants achieved 5% or greater weight loss 93% achieved 10% or greater 83% achieved 15% or greater Moderate weight loss protocol (8mg target) For researchers who want significant weight loss but have a lower tolerance for side effects, stopping the escalation at 8mg is a validated approach

These effects enhanced the cytotoxicity of CD8+ T cells and their capacity to eliminate tumor cells, thereby augmenting the antitumor efficacy of PD-1 inhibitors (109,110)

Make it a habit Aim for 10 to 20 minutes of light to moderate movement soon after waking